Work

A Phase 2 Study of the MEK1/2 Inhibitor Luvometinib in Patients with Extracranial Arteriovenous Malformations

Year: 2026

Type: article

Study design: Clinical Trial

Source: Clinical Cancer Research

DOI: 10.1158/1078-0432.ccr-26-0149

Authors: Chen Hua, Zhuli Wu, Xingli Wang, Huilong Liu, Ben Li, Yang Zheng, Xiaoxi Lin

Institutions: Shanghai Jiao Tong University, Shanghai Ninth People's Hospital, Fosun Pharma (China)

Language: English

Topic: Vascular Malformations and Hemangiomas

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7160983020

FWCI: 6.513

Cites: 30

Cited by: 1

Related to: